Consensus Orchid Pharma Limited Bombay S.E.

Equities

ORCHPHARMA

INE191A01027

Market Closed - Bombay S.E. Other stock markets 06:00:53 2024-07-16 am EDT			5-day change	1st Jan Change
1,148 ^INR	+2.65%		-0.38%	+60.83%

Jun. 28	Orchid Pharma Partners with Cipla to Launch Antibiotic Cefepime- Enmetazobactam in India	CI
Jun. 06	Orchid Pharma Gets Indian Regulator's Nod for Enmetazobactam	MT

Evolution of the average Target Price on Orchid Pharma Limited

Price target over the last 5 years

History of analyst recommendation changes

289cfa16675d0ab68027d.9Nd-u1qJx1fGaTCFi7QlVAYoxMbMy4iLnS7nqaLnWGU.mZ0xwm-4rD6nX1iyxvN8Z3N6hamV8_rJ1kumzJWsAQ3Zvi3RasyfEo5dXw~5ecdb9870a5490263b0362f0a3d9c0d6

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,140 INR

Average target price

1,252 INR

Spread / Average Target

+9.87%

High Price Target

1,285 INR

Spread / Highest target

+12.73%

Low Price Target

1,225 INR

Spread / Lowest Target

+7.47%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar